Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Other Working Capital Changes: 2021-2025

Historic Other Working Capital Changes for Krystal Biotech (KRYS) over the last 5 years, with Sep 2025 value amounting to $1.4 million.

  • Krystal Biotech's Other Working Capital Changes rose 358.40% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year increase of 259.48%. This contributed to the annual value of $8.9 million for FY2024, which is 452.67% up from last year.
  • Krystal Biotech's Other Working Capital Changes amounted to $1.4 million in Q3 2025, which was up 7,226.32% from -$19,000 recorded in Q2 2025.
  • Over the past 5 years, Krystal Biotech's Other Working Capital Changes peaked at $6.9 million during Q4 2024, and registered a low of -$1.3 million during Q1 2021.
  • Over the past 3 years, Krystal Biotech's median Other Working Capital Changes value was $523,000 (recorded in 2023), while the average stood at $1.3 million.
  • As far as peak fluctuations go, Krystal Biotech's Other Working Capital Changes spiked by 1,967.86% in 2023, and later plummeted by 288.89% in 2024.
  • Over the past 5 years, Krystal Biotech's Other Working Capital Changes (Quarterly) stood at $1.7 million in 2021, then declined by 4.80% to $1.6 million in 2022, then crashed by 30.26% to $1.1 million in 2023, then skyrocketed by 503.66% to $6.9 million in 2024, then spiked by 358.40% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, -$19,000 for Q2 2025, and $3.0 million during Q1 2025.